Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gerard

Showing results (291-300 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Journal of Lipid Research|October 30, 2012
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosisAlison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, et al.
Molecular Therapy Oncolytics|November 15, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Toxins|September 27, 2024
Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog ModelRose H Dicovitsky, Jill T Schappa, Ashley J Schulte, et al.
Cancer Research Communications|May 17, 2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionJong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, et al.
Epilepsia|February 13, 2003
Exploration of a putative susceptibility locus for idiopathic generalized epilepsy on chromosome 8p12Thomas Sander, Christine Windemuth, Herbert Schulz, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, N Alpay Temiz, Stéphane Keita, et al.
Pageof 31

Showing results (291-300 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Journal of Lipid Research|October 30, 2012
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosisAlison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, et al.
Molecular Therapy Oncolytics|November 15, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcomaKelly M Makielski, Aaron L Sarver, Michael S Henson, et al.
Journal of Medicinal Chemistry|July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in miceGraeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Toxins|September 27, 2024
Toxicity Profile of eBAT, a Bispecific Ligand-Targeted Toxin Directed to EGFR and uPAR, in Mice and a Clinical Dog ModelRose H Dicovitsky, Jill T Schappa, Ashley J Schulte, et al.
Cancer Research Communications|May 17, 2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionJong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, et al.
Epilepsia|February 13, 2003
Exploration of a putative susceptibility locus for idiopathic generalized epilepsy on chromosome 8p12Thomas Sander, Christine Windemuth, Herbert Schulz, et al.
Journal of Medicinal Chemistry|February 27, 2010
Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): a potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidateHong C Shen, Fa-Xiang Ding, Subharekha Raghavan, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNKMichael Korenjak, N Alpay Temiz, Stéphane Keita, et al.
Pageof 31